Document Detail


The Homeostasis Model Assessment-adiponectin (HOMA-AD) is the most sensitive predictor of insulin resistance in obese children.
MedLine Citation:
PMID:  22265325     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: The aim of this study was to examine the efficacy of three indices i.e. adiponectin/leptin ratio, HOMA-IR and HOMA-AD in assessing insulin resistance among obese children. PATIENTS AND METHODS: One hundred and twenty-two obese children (57 girls, 65 boys): mean age 13.7±1.3 years, BMI 30.1±4.5kg/m(2), eight tanner stage I, 48 tanner stage II-III, 66 tanner stage IV-V, participated in this study. They were classified into four groups according to sex and the presence of metabolic syndrome characteristics: with metabolic syndrome (MS; 21 girls and 36 boys) and controls without metabolic syndrome (CON, 36 girls and 29 boys). The correlations between these three indices of insulin resistance and the MS criteria were analyzed using linear and multiple regressions and receiver operating characteristics (ROC) curves analysis. RESULTS: The majority of anthropometric and biological parameters as well as adiponectin/leptin ratio, HOMA-IR and HOMA-AD were significantly different between MS and CON in both sexes. Both HOMA-AD and HOMA-IR were significantly correlated with the majority of metabolic syndrome components than was the adiponectin/leptin ratio in MS of both sexes. In boys and girls with and without MS, multiple regression analyses highlighted that both HOMA-AD and adiponectin/leptin ratio (r=-0.99 and r=-0.54 for MS girls and boys respectively, 0.05<P<0.001), and HOMA-AD and HOMA-IR (r=0.66 and r=0.31 for MS girls and boys respectively, 0.05<P<0.01) affected each other but did not adiponectin/leptin ratio and HOMA-IR. Additionally, the area under the ROC curves for predicting insulin resistance were 0.69 (CI 95%, 0.60-0.77), 0.68 (CI 95%, 0.59-0.76) and 0.71 (CI 95%, 0.62-0.79) for adiponectin/leptin ratio, HOMA-IR and HOMA-AD, respectively. CONCLUSION: The current study strengthens the validity of the HOMA-AD as an adequate tool for determining insulin resistance among obese children with MS.
Authors:
Emna Makni; Wassim Moalla; Gérard Lac; Chirine Aouichaoui; Daniel Cannon; Mohamed Elloumi; Zouhair Tabka
Related Documents :
22039525 - Thrombospondin1 deficiency reduces obesity-associated inflammation and improves insulin...
10332565 - Androgens and abdominal obesity.
11805435 - The autosomal dominant trait of obesity, acanthosis nigricans, hypertension, ischemic h...
12177035 - Insulin resistance syndrome revisited: application of self-organizing maps.
6106215 - 13c n.m.r. studies of gluconeogenesis in rat liver suspensions and perfused mouse livers.
19049375 - Diabetes distress and its association with clinical outcomes in patients with type 2 di...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-19
Journal Detail:
Title:  Annales d'endocrinologie     Volume:  -     ISSN:  0003-4266     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0116744     Medline TA:  Ann Endocrinol (Paris)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Masson SAS.
Affiliation:
Laboratory of cardiocirculatory, respiratory, and hormonal adaptations to muscular exercise 99/0867, faculty of medicine Ibn El Jazzar, Sousse University, Sousse, Tunisia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relationship between baseline ET-1 plasma levels and outcome in patients with idiopathic pulmonary h...
Next Document:  Von Hippel-Lindau disease and aggressive GH-PRL pituitary adenoma in a young boy.